ATLAS / Macro Radar / Reporting / ASBP

Aspire Biopharma Holdings, Inc. (ASBP) reporting calendar

Aspire Biopharma Holdings, Inc. files periodic reports with the SEC as ASBP on Nasdaq. Atlas tracks 17 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
19 Jul 2026 – 9 Sep 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
15 May 2026
Reports on record
17

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 45 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Open ASBP market profile Latest filing on SEC EDGAR ↗ Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202615 May 202645 days0001493152-26-023802
10-K31 Dec 202530 Mar 202689 days0001493152-26-013682
10-Q30 Sep 202514 Nov 202545 days0001493152-25-022595
10-Q30 Jun 202513 Aug 202544 days0001641172-25-023573
10-Q31 Mar 202514 May 202544 days0001641172-25-010316
10-K31 Dec 20247 Apr 202597 days0001641172-25-002917
10-Q30 Sep 202414 Nov 202445 days0001493152-24-045850
10-Q30 Jun 202416 Aug 202447 days0001493152-24-032815
10-Q31 Mar 20245 Jun 202466 days0001493152-24-022728
10-K31 Dec 202311 Mar 202471 days0001493152-24-009602
10-Q30 Sep 20238 Nov 202339 days0001493152-23-039795
10-Q30 Jun 20238 Aug 202339 days0001410578-23-001594
10-Q31 Mar 202311 May 202341 days0001410578-23-001031
10-K31 Dec 202221 Mar 202380 days0001410578-23-000316
10-Q30 Sep 202210 Nov 202241 days0001410578-22-003172
10-Q30 Jun 202211 Aug 202242 days0001410578-22-002287
10-Q31 Mar 202216 May 202246 days0001410578-22-001691

Source: SEC EDGAR company submissions for CIK 0001847345. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.